Alexey Bersenev, who maintains the long-running stem cells/regenerative medicine blog Hematopoiesis, graciously invited me to respond to a few questions about recent developments in stem cell pseudomedicine, where the industry stands today, and where it might be heading in the future. Interested readers can click through to the full Q&A here.